Automated Breast Ultrasound Systems (ABUS) Market Size 2026-2030
The automated breast ultrasound systems (abus) market size is valued to increase by USD 1.01 billion, at a CAGR of 16.8% from 2025 to 2030. Increasing demand for breast imaging products owing to prevalence of breast cancer cases will drive the automated breast ultrasound systems (abus) market.
Major Market Trends & Insights
- North America dominated the market and accounted for a 33.4% growth during the forecast period.
- By End-user - Diagnostic centers segment was valued at USD 384.8 million in 2024
- By Product Type - ABVS segment accounted for the largest market revenue share in 2024
Market Size & Forecast
- Market Opportunities: USD 1.38 billion
- Market Future Opportunities: USD 1.01 billion
- CAGR from 2025 to 2030 : 16.8%
Market Summary
- The automated breast ultrasound systems (ABUS) market is defined by its critical role in addressing the diagnostic limitations of mammography, particularly in patients with dense breast tissue. Growth is propelled by the rising global incidence of breast cancer and a clinical shift toward early, more personalized detection strategies.
- A significant trend shaping the industry is the integration of artificial intelligence and machine learning algorithms, which enhance lesion characterization and reduce interpretation time for radiologists. Concurrently, the focus on developing more affordable and portable systems is expanding access beyond large hospitals to smaller clinics.
- However, the market faces challenges related to the high capital cost of equipment and the need for specialized training for sonographers and radiologists to ensure proficient operation and accurate interpretation.
- For instance, an imaging center looking to adopt this technology must balance the significant upfront investment with the long-term benefits of improved diagnostic accuracy and patient throughput, while also planning for comprehensive staff training and workflow integration to maximize return on investment. The interplay of these dynamics continues to shape the adoption and evolution of these vital diagnostic tools.
What will be the Size of the Automated Breast Ultrasound Systems (ABUS) Market during the forecast period?
Get Key Insights on Market Forecast (PDF) Request Free Sample
How is the Automated Breast Ultrasound Systems (ABUS) Market Segmented?
The automated breast ultrasound systems (abus) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2026-2030, as well as historical data from 2020-2024 for the following segments.
- End-user
- Diagnostic centers
- Hospitals and clinics
- Product type
- ABVS
- ABUS
- AWBU
- Application
- Breast cancer screening
- Diagnostic imaging
- Pre-operative evaluation
- Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Asia
- Rest of World (ROW)
- North America
By End-user Insights
The diagnostic centers segment is estimated to witness significant growth during the forecast period.
Standalone diagnostic centers represent a rapidly expanding segment, prioritizing high patient throughput and operational efficiency.
These facilities strategically invest in advanced technology, such as the automated breast volume scanner (ABVS) and automated whole breast ultrasound (AWBU), as a key market differentiator.
The use of high-frequency transducers allows for superior 3D image reconstruction and volumetric data analysis. This commitment to cutting-edge tools facilitates enhanced diagnostic workup enhancement and more accurate mammographically occult cancer detection.
Operator-independent imaging, a core feature, reduces procedural variability by over 40%, ensuring standardized quality and supporting better surgical planning accuracy.
The technology's capacity for coronal plane imaging offers a unique perspective for treatment response monitoring and identifying multifocal disease, making it a critical breast cancer screening adjunct.
The Diagnostic centers segment was valued at USD 384.8 million in 2024 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 33.4% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
See How Automated Breast Ultrasound Systems (ABUS) Market Demand is Rising in North America Request Free Sample
The geographic landscape is led by North America, which accounts for over 33% of incremental growth, driven by favorable patient notification laws and high healthcare spending.
Asia is the fastest-growing region, fueled by rising incomes, government health initiatives, and a high prevalence of dense breast tissue affecting up to 50% of the female population. Europe maintains a strong position with its emphasis on advanced medical technology.
Across all regions, the implementation of workflow optimization tools is a priority, with integrated systems demonstrating a 20% improvement in imaging center throughput. The use of machine learning algorithms for clinical decision support is standardizing diagnostic procedures.
These algorithms help in reducing inter-observer variability and improving diagnostic confidence scores.
Such advancements in preventive medicine applications are critical for effective image data management and supporting longitudinal study comparison, regardless of the ultrasound probe positioning and its integration for fetal assessment automation or cardiac measurement automation.
Market Dynamics
Our researchers analyzed the data with 2025 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
- Healthcare providers evaluating the future of automated breast imaging are increasingly analyzing the comparative benefits of ABUS vs digital breast tomosynthesis, particularly for ABUS for dense breast tissue. The integration of AI in automated breast ultrasound is a pivotal factor, as it directly addresses the cost-effectiveness of ABUS screening by enhancing accuracy and reducing radiologist workload.
- A key consideration is the training requirements for ABUS technologists, which are essential for minimizing operator variability in handheld vs ABUS examinations. To ensure financial viability, understanding reimbursement codes for ABUS procedures is critical.
- From a clinical perspective, the role of ABUS in pre-operative surgical planning is expanding, as its ability to visualize the 3D coronal plane in ABUS aids in identifying the full extent of disease. This capability helps reduce false positives with ABUS, improving the diagnostic pathway.
- The emergence of the portable ABUS system for clinics is broadening access, though this necessitates seamless solutions to integrate ABUS with PACS and EHR. For ongoing patient care, ABUS for high-risk patient monitoring is proving valuable, supported by consistent software updates for ABUS platforms that enhance features.
- The patient experience with ABUS scanning, coupled with positive outcomes from clinical trials on ABUS efficacy, strengthens the case for investment. Ultimately, navigating the regulatory approval for ABUS devices remains a final, crucial step for market participants. Facilities that successfully integrate these systems into their digital infrastructure report workflow efficiency gains nearly double those of centers with standalone systems.
What are the key market drivers leading to the rise in the adoption of Automated Breast Ultrasound Systems (ABUS) Industry?
- The rising global prevalence of breast cancer is a key driver, increasing the demand for advanced breast imaging products like automated breast ultrasound systems (ABUS).
- Market growth is fundamentally driven by the rising need for more effective diagnostic tools to supplement traditional methods like digital breast tomosynthesis (DBT).
- With the increasing adoption of value-based healthcare models, technologies that improve early detection, such as contrast-enhanced mammography and opto-acoustic imaging, are gaining traction.
- The integration of ABUS with existing hospital infrastructure, including picture archiving communication system (PACS) and EHR integration, is critical, with connected systems improving data accessibility by over 40%.
- The demand for portable ultrasound systems is rising, driven by medical tourism services and public health initiatives expanding care to remote areas.
- These systems, often equipped with advanced ultrasound image analysis software and tele-ultrasound capabilities, enable specialized consultations regardless of location. Furthermore, advanced needle guidance systems are improving the accuracy of biopsies, reducing procedural complications by up to 25%.
What are the market trends shaping the Automated Breast Ultrasound Systems (ABUS) Industry?
- Increasing funding and capital investments for the development of automated breast ultrasound systems (ABUS) are a key upcoming trend. This financial support is accelerating innovation in imaging precision and diagnostic workflows.
- Key market trends are centered on enhancing clinical efficiency and expanding accessibility through technological innovation. The growing adoption of operator-independent imaging is streamlining the diagnostic imaging workflow, with facilities reporting a 15% reduction in scan time variability. This is particularly impactful for pre-operative evaluation and dense breast tissue screening.
- The development of advanced real-time tissue elastography provides better lesion characterization, improving diagnostic accuracy. Furthermore, there is a strong focus on supplemental imaging modalities that align with evolving risk-adapted screening protocols. As patient notification laws become more widespread, the demand for effective healthcare provider training is increasing, influencing capital equipment investment decisions in outpatient imaging center adoption.
- The reimbursement policy impact remains a critical factor shaping the pace of technology uptake across different regions.
What challenges does the Automated Breast Ultrasound Systems (ABUS) Industry face during its growth?
- Software corruption in ultrasound machines presents a significant challenge, potentially affecting the reliability and adoption of automated breast ultrasound systems (ABUS) and impacting market growth.
- Significant challenges persist, primarily related to system reliability, data management, and user expertise. The integrity of ultrasound system software is a key concern, as malfunctions can compromise the quality of 3D volumetric images and the effectiveness of computer-aided detection (CAD) tools. An effective image acquisition protocol is essential for quality, yet inconsistencies can lead to diagnostic errors.
- New systems featuring a patient-adaptive interface and a curved transducer array aim to improve image consistency by ensuring better tissue contact. However, managing the large datasets from doppler ultrasound imaging requires robust, secure solutions, pushing the demand for cloud-enabled imaging solutions. Protecting this information is paramount due to strict data security in imaging regulations.
- A primary operational hurdle is the radiologist reading time, which, despite technological aids, remains a bottleneck, impacting the overall throughput for high-risk patient screening and early cancer detection with non-ionizing radiation imaging.
Exclusive Technavio Analysis on Customer Landscape
The automated breast ultrasound systems (abus) market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the automated breast ultrasound systems (abus) market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape of Automated Breast Ultrasound Systems (ABUS) Industry
Competitive Landscape
Companies are implementing various strategies, such as strategic alliances, automated breast ultrasound systems (abus) market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Becton Dickinson and Co. - The vendor provides advanced automated breast ultrasound systems, enhancing diagnostic precision for dense breast tissue imaging and supporting improved clinical outcomes through innovative technology.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Becton Dickinson and Co.
- Canon Inc.
- CapeRay Medical Pty Ltd.
- Esaote Spa
- FUJIFILM Holdings Corp.
- GE Healthcare Technologies
- Hologic Inc.
- iVu Imaging Corp.
- Koninklijke Philips NV
- MetriTrack Inc.
- QT Imaging Inc.
- QView Medical Inc.
- Seno Medical Instruments Inc.
- Shenzhen Mindray BioMedical
- Siemens AG
- SonoCine Inc.
- SuperSonic Imagine
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Automated breast ultrasound systems (abus) market
- In September 2024, The Canadian Task Force on Preventive Health Care updated its guidelines to formally recommend automated breast ultrasound as a co-primary screening modality alongside mammography for women with extremely dense breast tissue.
- In December 2024, Siemens Healthineers launched the Acuson Maple, a versatile and portable ultrasound system incorporating AI-powered tools designed to improve diagnostic efficiency and workflow in various clinical settings.
- In April 2025, GE HealthCare unveiled a new generation ABUS system featuring an AI-powered decision support tool designed to pre-analyze volumetric data and flag suspicious regions, aiming to improve radiologist workflow and diagnostic confidence.
- In May 2025, DeepSight Technology announced it had received FDA 510(k) clearance for its NeedleVue LC1 Ultrasound System, an innovative platform designed to improve accuracy and safety in image-guided interventions.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Automated Breast Ultrasound Systems (ABUS) Market insights. See full methodology.
| Market Scope | |
|---|---|
| Page number | 292 |
| Base year | 2025 |
| Historic period | 2020-2024 |
| Forecast period | 2026-2030 |
| Growth momentum & CAGR | Accelerate at a CAGR of 16.8% |
| Market growth 2026-2030 | USD 1010.2 million |
| Market structure | Fragmented |
| YoY growth 2025-2026(%) | 14.4% |
| Key countries | US, Canada, Mexico, Germany, UK, France, Italy, Spain, The Netherlands, China, Japan, South Korea, India, Indonesia, Thailand, Brazil, Saudi Arabia, UAE, Turkey, Argentina, Colombia, South Africa and Israel |
| Competitive landscape | Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Research Analyst Overview
- The automated breast ultrasound systems (ABUS) market is advancing beyond its initial application as a supplemental imaging modality into a cornerstone of comprehensive breast care. Systems are evolving with the integration of AI-powered radiomics and advanced components like high-frequency transducers, enabling superior 3D image reconstruction and real-time tissue elastography.
- This technological progression allows for enhanced lesion characterization and volumetric data analysis, including visualization of the crucial coronal plane imaging. For boardroom-level strategy, the decision to invest in an automated breast volume scanner (ABVS) or an automated whole breast ultrasound (AWBU) is now a matter of balancing capital outlay against the significant clinical and risk-mitigation benefits.
- Deploying platforms with operator-independent imaging and robust diagnostic imaging workflow tools is essential for pre-operative evaluation and ensuring consistent quality.
- Notably, systems incorporating advanced AI demonstrate up to a 20% increase in diagnostic confidence scores among radiologists, a compelling metric that justifies the investment by directly impacting patient outcomes and reducing potential liabilities from missed diagnoses in dense breast tissue screening.
What are the Key Data Covered in this Automated Breast Ultrasound Systems (ABUS) Market Research and Growth Report?
-
What is the expected growth of the Automated Breast Ultrasound Systems (ABUS) Market between 2026 and 2030?
-
USD 1.01 billion, at a CAGR of 16.8%
-
-
What segmentation does the market report cover?
-
The report is segmented by End-user (Diagnostic centers, and Hospitals and clinics), Product Type (ABVS, ABUS, and AWBU), Application (Breast cancer screening, Diagnostic imaging, and Pre‑operative evaluation) and Geography (North America, Europe, Asia, Rest of World (ROW))
-
-
Which regions are analyzed in the report?
-
North America, Europe, Asia and Rest of World (ROW)
-
-
What are the key growth drivers and market challenges?
-
Increasing demand for breast imaging products owing to prevalence of breast cancer cases, Software corruption in ultrasound machines
-
-
Who are the major players in the Automated Breast Ultrasound Systems (ABUS) Market?
-
Becton Dickinson and Co., Canon Inc., CapeRay Medical Pty Ltd., Esaote Spa, FUJIFILM Holdings Corp., GE Healthcare Technologies, Hologic Inc., iVu Imaging Corp., Koninklijke Philips NV, MetriTrack Inc., QT Imaging Inc., QView Medical Inc., Seno Medical Instruments Inc., Shenzhen Mindray BioMedical, Siemens AG, SonoCine Inc. and SuperSonic Imagine
-
Market Research Insights
- Market dynamics are increasingly shaped by the adoption of value-based healthcare models, where the focus on improved patient outcomes justifies capital equipment investment in advanced imaging. The impact of reimbursement policy impact is significant, with positive coverage decisions accelerating adoption in outpatient imaging center adoption.
- Risk-adapted screening protocols are becoming standard, creating sustained demand for technologies that can effectively stratify patient care. Healthcare provider training initiatives are critical for ensuring proper utilization, and successful programs have demonstrated the ability to reduce technologist onboarding time by up to 25%.
- Furthermore, institutions implementing these advanced systems within value-based frameworks report a 15% improvement in early-stage cancer detection rates, underscoring the technology’s clinical and financial benefits.
We can help! Our analysts can customize this automated breast ultrasound systems (abus) market research report to meet your requirements.